Meanwhile, the BSE Sensex was up 69.92 points, or 0.41% to 17,266.39.

On BSE, 7,512 shares were traded in the counter as against average daily volume of 2,744 shares in the past one quarter.

The stock hit a high of Rs 410.80 and a low of Rs 398 so far during the day. The stock had hit a 52-week high of Rs 485 on 8 July 2011. The stock had hit a 52-week low of Rs 360 on 24 October 2011.

The stock had outperformed the market in past one month till 22 March 2012. The scrip remained unchanged during that period, compared with the Sensex's 5.23% fall. The scrip had underperformed the market in past one quarter, falling 0.93% as against Sensex's 8.75% gain.

The small-cap company has an equity capital of Rs 12.29 crore. Face value per share is Rs 10.

The Indoco Remedies stock has surged 5.97% in two trading sessions from Rs 384.15 on 21 March 2012, after the company announced during trading hours on Thursday, 22 March 2012, its board would meet on 29 March 2012 to consider stock split and bonus. The stock had risen 2.7% to settle at Rs 394.55 on Thursday, 22 March 2012.

Indoco Remedies' net profit fell 6.2% to Rs 8.26 crore on 23.8% growth in net sales to Rs 141.52 crore in Q3 December 2011 over Q3 December 2010.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India. Indoco has a brand portfolio of 135 products in various therapeutic segments, including high growth life style segments such as anti-diabetics, cardiovascular, central nervous system, musculo-skeletal, nutrition and dental care.